filmov
tv
Application of PBPK Modeling in Pediatric Drug Development (GastroPlus®)
Показать описание
Simulations Plus, Inc.
Рекомендации по теме
0:22:23
Application of PBPK Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA
1:23:25
Application of PBPK Modeling in Pediatric Drug Development (GastroPlus®)
0:06:38
The Use of PBPK modeling in Drug Discovery
0:59:17
Applications of PBPK modelling for regulatory submissions: case studies
0:15:43
Module 7 – Case Study 5: Application of PBPK Models in Eliglustat Clinical Development
0:55:39
A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development
0:50:40
Application of PBPK Modeling in Predicting P-glycoprotein-Mediated Drug-Drug Interactions
0:57:41
Application of PBPK modeling & simulation to support dose selection in special populations
2:20:27
Application of PBPK Modeling in Pediatric Drug Development (GastroPlus®)
0:10:03
Introduction to PBPK modeling with PK-Sim 6
0:19:56
PBPK to Guide Study Design and Product Development for Generic Dermatological Products
0:40:57
Precision Dosing Using PBPK Modeling
1:23:40
Applications of GastroPlus PBPK Modeling at the FDA Office of Generic Drugs
0:03:18
The benefits of using Pharmacokinetic and Pharmacodynamic modeling
0:49:40
PBPK modeling and simulation: Bridging the “Bottom Up” and “Top-Down” Approaches
0:20:32
A physiologically based pharmacokinetic (PBPK) model of pravastatin
1:05:52
Application of Physiologically-based Pharmacokinetics (PBPK) to Personalized Dosing
1:26:54
Applications Experiences of PBPK Modeling to Support Regulatory Interactions
0:59:17
Strategic Application of PBPK Models for Predicting DDIs & the Effects of Smoking & Organ Im...
0:36:08
PBPK Modeling of Antibody-Drug Conjugates – Concept and Application
0:01:52
PBPK modeling supports approval of breakthrough cancer drug
0:50:49
PBPK Modeling and Simulation for Regulatory Decision Making: Impact on US Prescribing Information
0:36:18
Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)
0:30:46
Physiologically based pharmacokinetic modeling for the simulation of relevant clinical scenarios
0:22:23
1:23:25
0:06:38
0:59:17
0:15:43
0:55:39
0:50:40
0:57:41
2:20:27
0:10:03
0:19:56
0:40:57
1:23:40
0:03:18
0:49:40
0:20:32
1:05:52
1:26:54
0:59:17
0:36:08
0:01:52
0:50:49
0:36:18
0:30:46